Drug to treat canine lymphoma gets FDA approvalJanuary 3, 2017VetDC, Inc., a veterinary cancer therapeutics company, today announced that the U.S. Food and Drug Administration’s Center for Veterinary Medicine has granted a conditional approval of Tanovea™-CA1 (rabacfosadine for injection) for the treatment of lymphoma in dogs.
SPONSORED CONTENTA brighter future for parvovirus patientsOur Canine Parvovirus Monoclonal Antibody helps puppies recover faster, and current users report reductions in clinic stress during parvo treatment.1,2 Find out why veterinary teams are embracing CPMA. + Read More
